DANIELE JOHNSON: Open Payments
NPI 1487425369 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 34 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $305 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $144 |
| Merck Sharp & Dohme LLC | 4 | $109 |
| Lilly USA, LLC | 5 | $108 |
| Novo Nordisk Inc | 4 | $87 |
| PFIZER INC. | 3 | $74 |
| Exact Sciences Corporation | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Dexcom, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: CAPVAXIVE, MOUNJARO, VRAYLAR, Ozempic, The Cologuard Plus Collection Kit, JARDIANCE, Dexcom G6 Transmitter, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
